From Icebreaker to Insight: BD’s Guide to the First 30-Minute Call

The first 30 minutes of a call with a biotech sponsor isn't just about breaking the ice. It's your opportunity to shape the entire sales cycle.

And no matter how well-crafted your pitch or how polished your slide deck is, you can’t build trust if you’re only listening for keywords.

You have to guide the conversation like a partner, not a vendor.

Here’s how I think about those first 30 minutes, and what separates the reps who get ghosted from the ones who get the RFP.

---

1. Stop Looking for Buying Signals and Start Looking for Pressure Points

Too many BD pros start with surface-level rapport, then try to force-fit a capabilities overview. But that’s how you miss the real gold.

Your goal isn’t to diagnose; it’s to understand what’s driving urgency on their end:

• Is the pressure coming from funding deadlines?

• Are they struggling with internal alignment or strategy shifts?

• Do they already have CDMO scars from a past experience?

Ask questions that uncover the friction, not just the facts.

Pro Tip: Try something like “What’s making this timeline critical for you?” instead of “When do you need to start?”

---

2. Let the Biotech Tell Their Story, But Steer with Subtle Control

Founders and CMC leads usually appreciate the space to talk through their program. But it’s on you to frame the conversation so it doesn’t turn into a data dump.

You can guide with questions like:

• “Can you walk me through where you’ve been and where you’re trying to go?”

• “What’s already locked in, and what’s still flexible?”

• “Who else is involved in the CDMO selection process?”

These questions open the door while keeping the conversation structured. You want them to feel heard and supported and not like they’re rambling while you zone out waiting to pitch.

---

3. Don’t Pitch... Prioritize

This is the biggest misstep I see: jumping straight into capabilities, sites, or tech platforms without first understanding the sponsor’s actual needs.

In the first 30 minutes, your job is to prioritize, not promote.

What does the sponsor value most?

• Speed to clinic?

• Regulatory support?

• A smoother tech transfer than their last experience?

Once you know that, you can start shaping the narrative around how your CDMO helps solve that problem. But don’t pitch until they give you the opening.

---

4. Close the Call with Strategic Next Steps

You should walk away with a clear mutual understanding... not just “I’ll send you a deck.”

End the call by:

• Recapping what you heard as their top priorities

• Identifying any internal stakeholders who need to weigh in

• Setting expectations for what comes next (RFI, follow-up call, site intro, etc.)

And always ask, “Is there anything I missed or misunderstood?” It shows respect and gives them one more chance to clarify.

---

Final Thought

The first 30 minutes set the tone for everything that follows.

Done right, you don’t just move the conversation forward, you establish credibility, earn trust, and position yourself as the strategic partner they didn’t realize they needed.

If you’re still relying on decks and demos to do the heavy lifting, it’s time to elevate your approach.

My course, “Ask Smarter, Close Sooner,” walks you through how to build relationships, qualify faster, and guide biotech conversations from first touch to final signature. It’s built specifically for CDMO business development professionals who want to sell with confidence without sounding salesy.

---

For more insights and personalized support in navigating the biotech-CDMO landscape, visit my website: www.yourpharmagirl.com and follow Your Pharma Girl on LinkedIn. Whether you need strategic guidance, tailored BD solutions, or expert advice on building lasting partnerships, I'm here to help you and your team succeed at every stage of development.